Pekayvaz, Kami http://orcid.org/0000-0003-4040-650X
Losert, Corinna http://orcid.org/0000-0002-5997-4702
Knottenberg, Viktoria
Gold, Christoph
van Blokland, Irene V.
Oelen, Roy http://orcid.org/0000-0002-5026-6531
Groot, Hilde E.
Benjamins, Jan Walter http://orcid.org/0000-0002-5701-0539
Brambs, Sophia
Kaiser, Rainer http://orcid.org/0000-0003-1750-3395
Gottschlich, Adrian http://orcid.org/0000-0002-2898-4182
Hoffmann, Gordon Victor
Eivers, Luke
Martinez-Navarro, Alejandro http://orcid.org/0000-0003-3893-1719
Bruns, Nils
Stiller, Susanne
Akgöl, Sezer http://orcid.org/0000-0002-3154-3214
Yue, Keyang
Polewka, Vivien
Escaig, Raphael
Joppich, Markus http://orcid.org/0000-0002-6665-8951
Janjic, Aleksandar
Popp, Oliver
Kobold, Sebastian http://orcid.org/0000-0002-5612-4673
Petzold, Tobias http://orcid.org/0000-0001-7805-5632
Zimmer, Ralf
Enard, Wolfgang
Saar, Kathrin http://orcid.org/0000-0002-4483-1557
Mertins, Philipp http://orcid.org/0000-0002-2245-528X
Huebner, Norbert http://orcid.org/0000-0002-1218-6223
van der Harst, Pim
Franke, Lude H.
van der Wijst, Monique G. P. http://orcid.org/0000-0003-1520-3970
Massberg, Steffen http://orcid.org/0000-0001-7387-3986
Heinig, Matthias http://orcid.org/0000-0002-5612-1720
Nicolai, Leo http://orcid.org/0000-0003-0776-5885
Stark, Konstantin http://orcid.org/0000-0002-5369-8399
Article History
Received: 2 May 2023
Accepted: 26 March 2024
First Online: 21 May 2024
Competing interests
: S.K. has received honoraria from TCR2, Novartis, BMS, Galapagos, Miltenyi and GSK. S.K. received license fees from TCR2 and Carina Biotech. A.G. received research support from Tabby Therapeutics for work unrelated to the paper. S.K. received research support from TCR2, Plectonic, Catalym and Arcus Bioscience for work unrelated to the paper. The other authors declare no competing interests.